HDAC8 and nonpapillary renal cell carcinoma: We noticed that sunitinib treatment increased the protein level of HDAC8, and the sunitinib‐resistant ccRCC cells and patient samples had higher expression levels of HDAC8 than did the sunitinib‐sensitive cells (Figure 1J–M).